Boron-Containing Peptidomimetics - A Novel Class of Selective Anti-tubercular Drugs

Chemical Biology and Drug Design

Volumn 81, Issue 3, 2013, Pages 408-413

  Gorovoy, Alexey S ^a   Gozhina, Olga V ^a   Svendsen, John S ^a   Domorad, Anna A ^b   Tetz, George V ^b   Tetz, Victor V ^b   Lejon, Tore ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antibacterial peptides; Beta aminoboronates; Beta aminoboronic acids; Boronic acids; Matteson homologation; Peptidomimetics; Tuberculosis

Indexed keywords

BORON DERIVATIVE; PEPTIDOMIMETIC AGENT; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; DRUG SCREENING; ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84873747681     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12091     Document Type: Article

References (22)

1. Herzog H. (1998) History of tuberculosis. Respiration;65:5-15.
2. Donoghue H.D., Spigelman M., Greenblatt C., Lev-Maor L.G., Bar-Gal G.K., Matheson C., Vernon K., Nerlich A.G., Zink A.R. (2004) Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infect Dis;4:584-592.
3. Snell N.J.C. (1998) The treatment of tuberculosis: current status and future prospects. Expert Opin Investig Drugs;7:545-552.
4. Goldberg S., LoBue P. (2012) Pulmonary tuberculosis: focus on the fluoroquinolones. Clin Med Insights: Ther;2:341-352.
5. Rezanka T., Sigler K. (2008) Biologically active compounds of semi-metals. Phytochemistry;69:585-606.
6. Jabbour A., Smoum R., Takrouri K., Shalom E., Zaks B., Steinberg D., Rubinstein A., Goldberg I., Katzhendler J., Srebnik M. (2006) Pharmacologically active boranes. Pure Appl Chem;78:1425-1453.
7. Ivanov A.S., Zhalnina A.A., Shishkov S.V. (2009) A convergent approach to synthesis of bortezomib: the use of TBTU suppresses racemization in the fragment condensation. Tetrahedron;65:7105-7108.
8. Tomita M., Takase M., Bellamy W., Shimamura S. (1994) A review: the active peptide of lactoferrin. Acta Paediatr Jpn;36:585-591.
9. Haug B.E., Svendsen J.S. (2001) The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide. J Pept Sci;7:190-196.
10. Haug B.E., Skar M.L., Svendsen J.S. (2001) Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives. J Pept Sci;7:425-432.
11. Strom M.B., Haug B.E., Rekdal O., Skar M.L., Stensen W., Svendsen J.S. (2002) Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem Cell Biol;80:65-74.
12. Haug B.E., Stensen W., Stiberg T., Svendsen J.S. (2004) Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J Med Chem;47:4159-4162.
13. Cheng R.P., Gellman S.H., DeGrado W.F. (2001) β-Peptides: from structure to function. Chem Rev (Washington, DC);101:3219-3232.
14. Steer D.L., Lew R.A., Perlmutter P.A., Smith I., Aguilar M.-I. (2002) β-Amino acids: versatile peptidomimetics. Curr Med Chem;9:811-822.
15. Matteson D.S., Soloway A.H., Tomlinson D.W., Campbell J.D., Nixon G.A. (1964) Synthesis and biological evaluation of water-soluble 2-borono-ethylthio compounds. J Med Chem;7:640-643.
16. Matteson D.S. (2005) (α-Haloalkyl)boronic Esters in Asymmetric Synthesis. In: Hall D.G., editors. Boronic Acids. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, p. 305-342.
17. Thomas S.P., French R.M., Jheengut V., Aggarwal V.K. (2009) Homologation and alkylation of boronic esters and boranes by 1, 2-metallate rearrangement of boronate complexes. Chem Rec;9:24-39.
18. Ray R., Matteson D.S. (1980) Osmium tetroxide catalyzed hydroxylation of hindered olefins. Tetrahedron Lett;21:449-450.
19. Davoli P., Fava R., Morandi S., Spaggiari A., Prati F. (2005) Enantioselective total synthesis of (-)-microcarpalide. Tetrahedron;61:4427-4436.
20. Matteson D.S., Maliakal D., Fabry-Asztalos L. (2008) Synthesis of a (β-acetamido-α-acetoxyethyl)boronic ester via azido boronic esters. J Organomet Chem;693:2258-2262.
21. Snow R.J., Bachovchin W.W., Barton R.W., Campbell S.J., Coutts S.J., Freeman D.M., Gutheil W.G., Kelly T.A., Kennedy C.A., Krolikowski D.A., Leonard S.F., Pargellis C.A., Tong L., Adams J. (1994) Studies on proline boronic acid dipeptide inhibitors of dipeptidyl peptidase IV: identification of a cyclic species containing a B-N bond. J Am Chem Soc;116:10860-10869.
22. Wityak J., Earl R.A., Abelman M.M., Bethel Y.B., Fisher B.N., Kauffman G.S., Kettner C.A., Ma P., McMillan J.L. (1995) Synthesis of thrombin inhibitor DuP 714. J Org Chem;60:3717-3722.